Hamartoma risk factors: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:


==Overview==
==Overview==
The most potent risk factors in the development of hamartomas are familial hamartomatous syndromes, such as: [[Cowden syndrome]], Peutz-Jeghers syndrome, [[juvenile polyposis syndrome]], PTEN hamartoma tumor syndrome, hereditary mixed polyposis syndrome, [[tuberous sclerosis]], and Bannayan-Riley-Ruvalcaba syndrome.<ref name="pmid7855339">{{cite journal |vauthors=Brown K, Mund DF, Aberle DR, Batra P, Young DA |title=Intrathoracic calcifications: radiographic features and differential diagnoses |journal=Radiographics |volume=14 |issue=6 |pages=1247–61 |year=1994 |pmid=7855339 |doi=10.1148/radiographics.14.6.7855339 |url=}}</ref>
The most potent risk factors in the development of hamartomas are familial hamartomatous syndromes such as: [[Cowden syndrome]], [[Peutz-Jeghers syndrome]], [[juvenile polyposis syndrome]], PTEN hamartoma tumor syndrome, hereditary mixed polyposis syndrome, [[tuberous sclerosis]], and Bannayan-Riley-Ruvalcaba syndrome.<ref name="pmid7855339">{{cite journal |vauthors=Brown K, Mund DF, Aberle DR, Batra P, Young DA |title=Intrathoracic calcifications: radiographic features and differential diagnoses |journal=Radiographics |volume=14 |issue=6 |pages=1247–61 |year=1994 |pmid=7855339 |doi=10.1148/radiographics.14.6.7855339 |url=}}</ref>


==Risk Factors==
==Risk Factors==

Revision as of 16:22, 8 March 2016

Hamartoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hamartoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hamartoma risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hamartoma risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hamartoma risk factors

CDC on Hamartoma risk factors

Hamartoma risk factors in the news

Blogs on Hamartoma risk factors

Directions to Hospitals Treating Hamartoma

Risk calculators and risk factors for Hamartoma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

The most potent risk factors in the development of hamartomas are familial hamartomatous syndromes such as: Cowden syndrome, Peutz-Jeghers syndrome, juvenile polyposis syndrome, PTEN hamartoma tumor syndrome, hereditary mixed polyposis syndrome, tuberous sclerosis, and Bannayan-Riley-Ruvalcaba syndrome.[1]

Risk Factors

  • The most potent risk factors in the development of hamartomas are familial hamartomatous syndromes.
  • Familial syndromes associated with hamartomatous formation, include:[2]

References

  1. Brown K, Mund DF, Aberle DR, Batra P, Young DA (1994). "Intrathoracic calcifications: radiographic features and differential diagnoses". Radiographics. 14 (6): 1247–61. doi:10.1148/radiographics.14.6.7855339. PMID 7855339.
  2. Richardson MS (2016). "Familiar and unfamiliar pseudoneoplastic lesions of the head and neck". Semin Diagn Pathol. 33 (1): 24–30. doi:10.1053/j.semdp.2015.09.004. PMID 26739631.


Template:WikiDoc Sources